PROK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Prokidney Corp (PROK) is not a strong buy at this moment for a beginner, long-term investor with $50,000-$100,000 available for investment. While the company has shown significant revenue growth in the latest quarter, the lack of profitability, insider selling, and absence of positive trading signals suggest that it is better to hold off on investing in this stock right now.
The MACD is slightly positive at 0.0309, indicating mild bullish momentum, but it is contracting. RSI is neutral at 56.126, showing no clear overbought or oversold conditions. Moving averages are converging, suggesting indecision in price movement. The pre-market price is $1.99, slightly above the pivot point of $1.874 but below the first resistance level of $2.009.
Revenue increased significantly by 196.05% YoY in Q4 2025, indicating strong top-line growth. Gross margin remains at 100%, showing operational efficiency.
Insiders are selling heavily, with a 503.05% increase in selling activity over the last month. The company is still unprofitable, with net income dropping by -9.62% YoY and EPS declining by -17.65% YoY. No recent news or event-driven catalysts. No recent congress trading activity.
In Q4 2025, revenue grew by 196.05% YoY to $225,000, but net income fell to -$19.23 million (-9.62% YoY), and EPS dropped to -$0.14 (-17.65% YoY). Gross margin remained stable at 100%.
No analyst rating or price target changes are available for this stock.
